Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

TS Bowen, G Schuler, V Adams - Journal of cachexia …, 2015 - Wiley Online Library
Skeletal muscle provides a fundamental basis for human function, enabling locomotion and
respiration. Transmission of external stimuli to intracellular effector proteins via signalling …

Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies

A Martin, D Freyssenet - Journal of cachexia, sarcopenia and …, 2021 - Wiley Online Library
Cancer cachexia is a complex multi‐organ catabolic syndrome that reduces mobility,
increases fatigue, decreases the efficiency of therapeutic strategies, diminishes the quality of …

[HTML][HTML] Respiratory sarcopenia and sarcopenic respiratory disability: concepts, diagnosis, and treatment

A Nagano, H Wakabayashi, K Maeda, Y Kokura… - The journal of nutrition …, 2021 - Springer
The condition of muscle fiber atrophy and weakness that occurs in respiratory muscles along
with systemic skeletal muscle with age is known as respiratory sarcopenia. The Japanese …

Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle

G Wang, AK Biswas, W Ma, M Kandpal, C Coker… - Nature medicine, 2018 - nature.com
Patients with metastatic cancer experience a severe loss of skeletal muscle mass and
function known as cachexia. Cachexia is associated with poor prognosis and accelerated …

HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy

AW Beharry, PB Sandesara, BM Roberts… - Journal of cell …, 2014 - journals.biologists.com
ABSTRACT The Forkhead box O (FoxO) transcription factors are activated, and necessary
for the muscle atrophy, in several pathophysiological conditions, including muscle disuse …

[HTML][HTML] Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia

SM Judge, CL Wu, AW Beharry, BM Roberts… - BMC cancer, 2014 - Springer
Background Evidence from cachectic cancer patients and animal models of cancer cachexia
supports the involvement of Forkhead box O (FoxO) transcription factors in driving cancer …

Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching

B Ahn, R Ranjit, P Premkumar… - Journal of cachexia …, 2019 - Wiley Online Library
Background Excess reactive oxygen species (ROS) and muscle weakness occur in parallel
in multiple pathological conditions. However, the causative role of skeletal muscle …

The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin‐6

BN VanderVeen, DK Fix, RN Montalvo… - Experimental …, 2019 - Wiley Online Library
New Findings What is the central question of this study? Interleukin‐6 has been associated
with muscle mass and metabolism in both physiological and pathological conditions. A …

[HTML][HTML] The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy

FA Graca, M Rai, LC Hunt, A Stephan, YD Wang… - Nature …, 2022 - nature.com
Decline in skeletal muscle cell size (myofiber atrophy) is a key feature of cancer-induced
wasting (cachexia). In particular, atrophy of the diaphragm, the major muscle responsible for …

Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass

SMLM Looijaard, ML te Lintel Hekkert… - Acta …, 2021 - Wiley Online Library
Low skeletal muscle mass is highly prevalent in older cancer patients and affects 5% to 89%
depending on the type and stage of cancer. Low skeletal muscle mass is associated with …